Rapid Micro Biosystems, Inc.
RPID
Rank in Stocks
#24426
Rapid Micro Biosystems, Inc. operates as a life sciences technology firm,... Rapid Micro Biosystems, Inc. operates as a life sciences technology firm, supplying advanced solutions for identifying microbial impurities in the production processes of pharmaceuticals, medical devices, and personal care goods across North America, Europe, and Asia. Central to their offerings is the Growth Direct platform, a comprehensive system comprising the Growth Direct instrument, specialized disposable components, software for seamless integration with laboratory information management systems (LIMS), and extensive customer validation and support services. This innovative platform is designed to automate and modernize traditional, labor-intensive microbial quality control (MQC) testing workflows, which are critical for diverse therapeutic modalities such as biologics, vaccines, cutting-edge cell and gene therapies, and sterile injectable medications. Beyond their core product, the company also delivers essential services, including system installation, verification, expert technical training, and continuous support. Their technologies are widely applied in vital areas like environmental monitoring, water quality testing, bioburden assessment, and final sterility release evaluations. Established in 2006, the company initially traded as Genomic Profiling Systems, Inc., before rebranding to Rapid Micro Biosystems, Inc. in January 2007, and maintains its headquarters in Lowell, Massachusetts.
Share Price
$0.73
Last synced: 2026-11-09
Market Cap
$33.33M
Change (1 day)
13.85%
Change (1 year)
-80.59%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Rapid Micro Biosystems, Inc. (RPID)
Category
Healthcare
Operating Margin for Rapid Micro Biosystems, Inc. (RPID)
Operating Margin as of November 2026 TTM: -141.45%
According to Rapid Micro Biosystems, Inc.'s latest financial reports, its current operating margin (TTM) is -141.45%. At the end of 2025 the company had an operating margin of -141.10%.
Operating Margin history for Rapid Micro Biosystems, Inc. from 2019 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -141.45% | 0.25% |
| 2025 | -141.10% | -20.71% |
| 2024 | -177.96% | -29.15% |
| 2023 | -251.18% | -31.93% |
| 2022 | -368.99% | 81.49% |
| 2021 | -203.31% | 7.03% |
| 2020 | -189.96% | 68.33% |
| 2019 | -112.85% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 15.24% | -100.11% |
US
|
|
| 18.08% | -100.13% |
IE
|
|
| 21.25% | -100.15% |
US
|
|
| 21.05% | -100.15% |
US
|
|
| 28.09% | -100.20% |
US
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Rapid Micro Biosystems, Inc.'s operating margin
What is Rapid Micro Biosystems, Inc.'s operating margin?
Rapid Micro Biosystems, Inc.'s operating margin is -141.45%, as of Nov 2026.
What was Rapid Micro Biosystems, Inc.'s operating margin in 2025?
In 2025, Rapid Micro Biosystems, Inc.'s operating margin was -141.10%, compared with -177.96% in 2024.
How has Rapid Micro Biosystems, Inc.'s operating margin changed since 2020?
From 2020 to 2025, Rapid Micro Biosystems, Inc.'s operating margin was highest in 2025 (-141.10%) and lowest in 2022 (-368.99%).
How does Rapid Micro Biosystems, Inc.'s operating margin compare with similar companies?
Rapid Micro Biosystems, Inc.'s operating margin (-141.45%) is lower than that of all 5 similar companies listed above. The highest among them is Edwards Lifesciences Corporation, with 28.09%.